BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2875547)

  • 1. Treatment of reflux esophagitis with histamine H2-receptor antagonists.
    Kishi S; Tsuzi Y; Matsumura M; Kakutani A; Ito S; Mori H
    Tokushima J Exp Med; 1985 Dec; 32(3-4):65-70. PubMed ID: 2875547
    [No Abstract]   [Full Text] [Related]  

  • 2. [H2-blockers in reflux-esophagitis].
    Berstad A
    Tidsskr Nor Laegeforen; 1983 Jul; 103(19-21):1439-41. PubMed ID: 6138879
    [No Abstract]   [Full Text] [Related]  

  • 3. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H2 antagonists in the treatment of reflux esophagitis: a critical analysis.
    Stalnikowicz-Darvasi R
    Am J Gastroenterol; 1989 Mar; 84(3):245-8. PubMed ID: 2563926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatments in the short-term management of reflux esophagitis.
    Guirguis-Blake J
    Am Fam Physician; 2008 Mar; 77(5):620. PubMed ID: 18350759
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR
    Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
    Weiser HF; Gubernatis G; Siewert JR
    Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
    Vasil'ev IuV; Li IA
    Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cimetidine versus ranitidine in the treatment of peptic esophagitis].
    Noya G; Dettori G; Muscas A; Spirito R; Niolu P; Marongiu G; Biglioli P
    Minerva Med; 1983 Apr; 74(14-15):787-90. PubMed ID: 6132354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of gastroesophageal reflux: the role of proton pump inhibitors.
    Schulman MI; Orlando RC
    Adv Intern Med; 1995; 40():273-302. PubMed ID: 7747649
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medical treatment of gastroesophageal reflux in adults].
    Cadiot G
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):100-2. PubMed ID: 8737506
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reflux esophagitis: therapeutic indications].
    Cloarec D; Bruley des Varannes S; Galmiche JP
    Rev Prat; 1988 Feb; 38(4):237-48. PubMed ID: 2895495
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term therapy for reflux esophagitis.
    Tytgat GN
    N Engl J Med; 1995 Oct; 333(17):1148-50. PubMed ID: 7565956
    [No Abstract]   [Full Text] [Related]  

  • 14. Audit of reflux oesophagitis at 4 years.
    Pace F; Bollani S; Manzionna G; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):355-60. PubMed ID: 9789126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug treatment of reflux esophagitis: effects of strong gastric acid inhibition].
    Jansen JB; Lamers CB
    Ned Tijdschr Geneeskd; 1989 Apr; 133(13):662-5. PubMed ID: 2566126
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.
    Hamamoto N; Hashimoto T; Adachi K; Hirakawa K; Ishihara S; Inoue H; Taniura H; Niigaki M; Sato S; Kushiyama Y; Suetsugu H; Miyake T; Kinoshita Y
    J Gastroenterol Hepatol; 2005 Feb; 20(2):281-6. PubMed ID: 15683433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic approaches to healing esophagitis.
    Boyce HW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conservative therapy of reflux esophagitis].
    Koop H
    Z Gastroenterol Verh; 1990 Apr; 25():135-7. PubMed ID: 1694350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.